Taxanes for the treatment of breast cancer during pregnancy: an international cohort study

The addition of taxanes to anthracycline-based chemotherapy is considered standard of care in the treatment of breast cancer. However, there are insufficient data regarding the safety of taxanes during pregnancy. The aim of this study was to describe the incidence of obstetric and neonatal adverse e...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 2024-02, Vol.116 (2), p.239-248
Hauptverfasser:	Ferrigno Guajardo, Ana S, Vaca-Cartagena, Bryan F, Mayer, Erica L, Bousrih, Chayma, Oluchi, Oke, Saura, Cristina, Peccatori, Fedro, Muñoz-Montaño, Wendy, Cabrera-Garcia, Alvaro, Lambertini, Matteo, Corrales, Luis, Becerril-Gaitan, Andrea, Sella, Tal, Newman, Alexandra Bili, Pistilli, Barbara, Martinez, Ashley, Ortiz, Carolina, Joval-Ramentol, Laia, Scarfone, Giovanna, Buonomo, Barbara, Lara-Medina, Fernando, Sanchez, Jacqueline, Arecco, Luca, Ramos-Esquivel, Allan, Susnjar, Snezana, Morgan, Gilberto, Villarreal-Garza, Cynthia, Azim, Jr, Hatem A
Format:	Artikel
Sprache:	eng
Schlagworte:	Anthracyclines - adverse effects Antibiotics, Antineoplastic Breast Neoplasms - chemically induced Breast Neoplasms - drug therapy Breast Neoplasms - epidemiology Bridged-Ring Compounds Cohort Studies Female Humans Infant Infant, Newborn Pregnancy Taxoids - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!